Autonomix Medical, Inc. (AMIX) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US05330T3041
Autonomix Medical, Inc. financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 0.00 USD | 0.00 USD |
| Operating income | -11.59 m USD | -17.03 m USD |
| EBIT | -11.59 m USD | -17.03 m USD |
| Net income | -11.41 m USD | -16.72 m USD |
Full history since 2022, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Autonomix Medical, Inc.
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
More stocks
- BioAtla, Inc. (BCAB)
- Cannabis Bioscience International Holdings, Inc. (CBIH)
- LQR House Inc. (YHC)
- TurnOnGreen, Inc. (TOGI)
- BioXcel Therapeutics, Inc. (BTAI)
- Totaligent, Inc. (TGNT)
- ECO SCIENCE SOLUTIONS, INC. (ESSI)
- HONG YUAN HOLDING GROUP (HGYN)
- CERENOME, INC. (CNSY)
- Decentral Life, Inc. (WDLF)
- Calidi Biotherapeutics, Inc. (CLDI)
- NaturalShrimp Inc (SHMP)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.